Developer docs
API playgroundTry for free, no card

Search company profiles

Johnson Matthey - Medical Device Components Business

Full company profile

uuid003i7zg

Namestring
Johnson Matthey - Medical Device Components Business
Legal namestring
Johnson Matthey Plc
Websiteurl
matthey.com
Company typeenum
Public
Founded yearint
1817
Descriptiontext

Johnson Matthey's Medical Device Components Business manufactures precious metal and precision micromachined components for medical device original equipment manufacturers (OEMs). The business serves applications in cardiac rhythm management, neurovascular interventions, cochlear implants, and vascular interventions, supplying mission-critical components that must meet stringent biocompatibility, dimensional tolerance, and reliability standards. The product line is positioned within Johnson Matthey's broader portfolio under a dedicated "Medical-components" category accessible via the corporate product finder and a separate domain (medicaldevicecomponents.com), with ISO certificate requests managed through a dedicated contact channel, indicating the business is structured as a distinct operating unit with medical-grade quality systems.

The business draws on Johnson Matthey's foundational expertise in platinum group metals (PGM) chemistry, advanced metallurgy, and precision manufacturing — capabilities developed over more than 200 years since the company's founding in 1817. While the parent operates a diversified portfolio spanning transport (fuel cells, emissions control), energy (hydrogen, biorenewables, FCC additives, SAF), chemicals (syngas, ammonia, methanol, formaldehyde), PGMs and circularity (refining/recycling), and life science technologies, the medical device components unit specifically leverages PGM and precious-metal precision micromachining to deliver components for implantable and interventional medical devices. The product description states the components are manufactured for "cardiac rhythm management, neurovascular, cochlear, and vascular interventions," implying Class II/III medical device supply chain positioning.

The business operates a B2B enterprise sales model with direct technical engagement, regional manufacturing and distribution, and multi-year contract structures typical of mission-critical medical component supply. Pricing is quote-based and not publicly disclosed, consistent with customized industrial B2B procurement. The parent Johnson Matthey Plc is a UK public limited company listed on the London Stock Exchange (ticker: JMAT) with approximately 9,500 employees globally, operations in 25+ countries, and manufacturing facilities across the UK, US, Germany, Sweden, India, China, and Japan. The medical device components carve-out appears to be positioned as a focused, independently operable sub-business, given its distinct digital presence and dedicated compliance contact channels.

Short descriptiontext

Johnson Matthey's Medical Device Components Business manufactures precious metal and precision micromachined components for medical device OEMs, serving cardiac rhythm management, neurovascular, cochlear, and vascular intervention applications.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices12 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device components, precious metal components, precision micromachined parts, cardiac rhythm management, neurovascular device components
NAICS code4 codes
  • Turned Product and Screw, Nut, and Bolt Manufacturing33272
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
  • Medical Equipment and Supplies Manufacturing3391
SIC code2 codes
  • Screw Machine Products3451
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Device Components
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Catalysts and Chemical Products
TypeTransaction Fee
Description

Sale of catalysts, absorbents, and chemical products for industrial processes including methanol, ammonia, formaldehyde, hydrogenation, and refining applications

matthey.com
2Process Technology Licensing
TypeLicensing Royalties
Description

Licensing of proprietary process technologies including methanol synthesis, formaldehyde production, syngas technologies, and hydrogen production. Provides technology packages with detailed engineering specifications.

matthey.com
3Fuel Cell Components
TypeHardware Sales
Description

Manufacturing and sale of catalyst-coated membranes and membrane electrode assemblies for hydrogen fuel cells

matthey.com
4PGM Refining and Recycling
TypeManaged Services
Description

World's largest recycler of platinum group metals, offering refining and recycling services. Recovers PGMs to minimum 99.95% purity for reuse in manufacturing

matthey.com
5Technical Services and Support
TypeProfessional Services
Description

Comprehensive technical support, catalyst optimization, plant audits, operational feedback, and performance optimization services

matthey.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1B2B enterprise pricing - customized quotes based on volume, contract terms, and specification requirements
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing is not publicly available. Contact through regional sales teams and technical experts. Process licensing and catalyst supply negotiated on project basis.

matthey.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 15 records shown
1KATALCO
Description

Market-leading methanol synthesis technology and catalyst brand

matthey.com
+14 more records
Core offering1 text field

Johnson Matthey's Medical Device Components Business manufactures precious metal and precision micromachined components for medical device manufacturers. The components are designed for use in cardiac rhythm management, neurovascular, cochlear, and vascular intervention applications. As a segment of Johnson Matthey, it leverages the parent company's 200+ years of platinum group metal chemistry expertise to deliver high-precision medical components.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • c. 112k additional tonnes NOx removed from tailpipes by JM catalytic converters in 2024/25
+6 more records
Product overview1 text field

Johnson Matthey is a world leader in platinum group metals (PGMs) with a 200+ year history. The company offers a diversified portfolio of products and technologies across five main segments: Transport (fuel cells, mobile emissions control), Energy (hydrogen, biorenewables, FCC additives, purification, sustainable aviation fuels), Chemicals (syngas technologies, ammonia, methanol, formaldehyde, oleochemicals, petrochemicals), PGMs and circularity (PGM chemicals, industrial products, refining and recycling), and Life science technologies (biocatalysis, pharma catalysts). The products and services span catalyst systems, process licensing technologies, purification solutions, and specialty chemical products. A 'Medical-components' category exists in their product finder but detailed product pages for medical device components are not present in the provided source data.

Product and service1 record
1Medical Components
CategoryMedical Device Components
Description

Precious metal and precision micromachined components for medical device applications including cardiac rhythm management, neurovascular, cochlear, and vascular interventions.

Scale indicator16 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Co-development of FT CANS (Fischer Tropsch) technology for sustainable aviation fuel production. Partnership includes Fulcrum Sierra Biofuels Plant for waste-to-fuels conversion. Also collaborating on carbon-negative renewable diesel projects and multiple SAF production plants worldwide.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Long-term strategic partnership for green hydrogen electrolyser components. Johnson Matthey supplies PGM components and expertise for electrolyser manufacturing.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Integrated solution for blue ammonia production combining Johnson Matthey's LCH reforming technology with Uhde's ammonia process. Jointly offers catalyst and technology package for decarbonized ammonia production with up to 99% CO2 capture.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Integrated solution for methanol to jet fuel technology combining Johnson Matthey and Honeywell UOP technologies for sustainable aviation fuel production.

Strategic tierStrategicTypeTechnology or Integration
Description

Joint development of catalytic pyrolysis technology for production of advanced biofuels. Partnership focused on renewable fuel production processes.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

BioForming technology partnership that enabled the world's first transatlantic commercial flight using 100% sustainable aviation fuel, demonstrating the viability of drop-in SAF.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Combined methanol/ammonia co-production technology partnership using Johnson Matthey and KBR's market-leading technologies for maximized efficiency and operational flexibility.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Contract manufacturer of active implantables and precision components for cardiac rhythm management, neuromodulation, and other implantable applications — comparable customer base and micromachining/assembly capabilities.

TypeDirect peer
Description

Large medical device contract manufacturer specializing in precision components and finished devices for cardiac, neuromodulation, and vascular markets — directly comparable in product category and customer base.

TypeDirect peer
Description

Contract manufacturer of precision medical devices and components including machining, assembly, and finished devices for surgical and interventional OEMs — comparable in precision-machined medical components.

TypeBroad incumbent
Description

Large-scale medical device contract manufacturer offering design, molding, and assembly for diagnostics and drug delivery — adjacent rather than direct, but competes for the same OEM program opportunities.

TypeDirect peer
Description

Specialist in precision micromachining of medical devices and implants, including complex components for cardiovascular, neurovascular, and orthopedic applications — directly comparable on micromachining capability and customer overlap.

TypeBroad incumbent
Description

Broader medical device components manufacturer focused on elastomeric and specialty containment/delivery components; overlaps with JM medical components in supplying primary packaging and functional components to injectable and device OEMs.

TypeDirect peer
Description

Medical device contract manufacturer of precision silicone and plastic components and finished devices for minimally invasive and surgical applications — overlaps in implantable and interventional device components.

TypeBroad incumbent
Description

Medical device components and specialty extrusion business serving interventional, surgical, and OEM customers — broader incumbent with overlap in precision components for vascular and interventional devices.

TypeDirect peer
Description

Contract designer/manufacturer of complex medical devices and components, with strength in optical, electronic, and fluid-based systems for neuro and surgical OEMs — comparable as a specialist medtech CDMO.

TypeDirect peer
Description

Direct competitor in precious-metal components and micromachined parts for implantable medical devices (cardiac, neurovascular, hearing). Closest analog to JM's medical device components offering due to overlap in materials (Pt/Ir, Au, Ta) and implantable device applications.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers13 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries9 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Johnson Matthey - Medical Device Components Business

Medical Device Componentsmatthey.com

Johnson Matthey's Medical Device Components Business manufactures precious metal and precision micromachined components for medical device OEMs, serving cardiac rhythm management, neurovascular, cochlear, and vascular intervention applications.

What Johnson Matthey - Medical Device Components Business does

Johnson Matthey's Medical Device Components Business manufactures precious metal and precision micromachined components for medical device original equipment manufacturers (OEMs). The business serves applications in cardiac rhythm management, neurovascular interventions, cochlear implants, and vascular interventions, supplying mission-critical components that must meet stringent biocompatibility, dimensional tolerance, and reliability standards. The product line is positioned within Johnson Matthey's broader portfolio under a dedicated "Medical-components" category accessible via the corporate product finder and a separate domain (medicaldevicecomponents.com), with ISO certificate requests managed through a dedicated contact channel, indicating the business is structured as a distinct operating unit with medical-grade quality systems.

The business draws on Johnson Matthey's foundational expertise in platinum group metals (PGM) chemistry, advanced metallurgy, and precision manufacturing — capabilities developed over more than 200 years since the company's founding in 1817. While the parent operates a diversified portfolio spanning transport (fuel cells, emissions control), energy (hydrogen, biorenewables, FCC additives, SAF), chemicals (syngas, ammonia, methanol, formaldehyde), PGMs and circularity (refining/recycling), and life science technologies, the medical device components unit specifically leverages PGM and precious-metal precision micromachining to deliver components for implantable and interventional medical devices. The product description states the components are manufactured for "cardiac rhythm management, neurovascular, cochlear, and vascular interventions," implying Class II/III medical device supply chain positioning.

The business operates a B2B enterprise sales model with direct technical engagement, regional manufacturing and distribution, and multi-year contract structures typical of mission-critical medical component supply. Pricing is quote-based and not publicly disclosed, consistent with customized industrial B2B procurement. The parent Johnson Matthey Plc is a UK public limited company listed on the London Stock Exchange (ticker: JMAT) with approximately 9,500 employees globally, operations in 25+ countries, and manufacturing facilities across the UK, US, Germany, Sweden, India, China, and Japan. The medical device components carve-out appears to be positioned as a focused, independently operable sub-business, given its distinct digital presence and dedicated compliance contact channels.

Johnson Matthey - Medical Device Components Business firmographics

Firmographics
Name
Johnson Matthey - Medical Device Components Business
Legal name
Johnson Matthey Plc
Website
https://matthey.com
Company type
Public
Founded year
1817
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Johnson Matthey's Medical Device Components Business manufactures precious metal and precision micromachined components for medical device OEMs, serving cardiac rhythm management, neurovascular, cochlear, and vascular intervention applications.
Ownership category
akta.pro rank

Where Johnson Matthey - Medical Device Components Business is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices12 records

Markets served

Johnson Matthey - Medical Device Components Business business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Catalysts and Chemical Products: Sale of catalysts, absorbents, and chemical products for industrial processes including methanol, ammonia, formaldehyde, hydrogenation, and refining applications
  2. Process Technology Licensing: Licensing of proprietary process technologies including methanol synthesis, formaldehyde production, syngas technologies, and hydrogen production. Provides technology packages with detailed engineering specifications.
  3. Fuel Cell Components: Manufacturing and sale of catalyst-coated membranes and membrane electrode assemblies for hydrogen fuel cells
  4. PGM Refining and Recycling: World's largest recycler of platinum group metals, offering refining and recycling services. Recovers PGMs to minimum 99.95% purity for reuse in manufacturing
  5. Technical Services and Support: Comprehensive technical support, catalyst optimization, plant audits, operational feedback, and performance optimization services

Pricing tiers

ModelBillingPrice
OtherMulti-year contractB2B enterprise pricing - customized quotes based on volume, contract terms, and specification requirements

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Johnson Matthey - Medical Device Components Business product offering

Product offering

Core offering

Johnson Matthey's Medical Device Components Business manufactures precious metal and precision micromachined components for medical device manufacturers. The components are designed for use in cardiac rhythm management, neurovascular, cochlear, and vascular intervention applications. As a segment of Johnson Matthey, it leverages the parent company's 200+ years of platinum group metal chemistry expertise to deliver high-precision medical components.

Product overview

Johnson Matthey is a world leader in platinum group metals (PGMs) with a 200+ year history. The company offers a diversified portfolio of products and technologies across five main segments: Transport (fuel cells, mobile emissions control), Energy (hydrogen, biorenewables, FCC additives, purification, sustainable aviation fuels), Chemicals (syngas technologies, ammonia, methanol, formaldehyde, oleochemicals, petrochemicals), PGMs and circularity (PGM chemicals, industrial products, refining and recycling), and Life science technologies (biocatalysis, pharma catalysts). The products and services span catalyst systems, process licensing technologies, purification solutions, and specialty chemical products. A 'Medical-components' category exists in their product finder but detailed product pages for medical device components are not present in the provided source data.

Differentiator

Problem solved

Functional benefit

Brands

  • KATALCO: Market-leading methanol synthesis technology and catalyst brand
  • FORMOX
  • PURASPEC
  • ActivCRT/ActivDPF
  • EASY-FLO/ALU-FLO
  • NONOX
  • SUPER SOXGETTER/LO-SOX PB
  • CAT-AID
  • BCA-105
  • FT CANS
  • HyCOgen
  • LCH/CLEANPACE
  • ADEPT
  • PRICAT
  • SWITCH METHANOL/PRECISION METHANOL/BALANCE METHANOL/PRIMARY METHANOL

Products and services

  • Medical Components Precious metal and precision micromachined components for medical device applications including cardiac rhythm management, neurovascular, cochlear, and vascular interventions.

Quantifiable outcome

  • c. 112k additional tonnes NOx removed from tailpipes by JM catalytic converters in 2024/25
  • +6 more outcomes

Companies that use Johnson Matthey - Medical Device Components Business

Customer profile

Named customers13 records

Segments6 records

Ideal customer profiles1 record

Johnson Matthey - Medical Device Components Business technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Johnson Matthey - Medical Device Components Business partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered flagship, core and strategic.

  • bpflagshipStrategic or Co-development PartnerCo-development of FT CANS (Fischer Tropsch) technology for sustainable aviation fuel production. Partnership includes Fulcrum Sierra Biofuels Plant for waste-to-fuels conversion. Also collaborating on carbon-negative renewable diesel projects and multiple SAF production plants worldwide.
  • Plug PowercoreStrategic or Co-development PartnerLong-term strategic partnership for green hydrogen electrolyser components. Johnson Matthey supplies PGM components and expertise for electrolyser manufacturing.
  • thyssenkrupp UhdecoreStrategic or Co-development PartnerIntegrated solution for blue ammonia production combining Johnson Matthey's LCH reforming technology with Uhde's ammonia process. Jointly offers catalyst and technology package for decarbonized ammonia production with up to 99% CO2 capture.
  • Honeywell UOPcoreStrategic or Co-development PartnerIntegrated solution for methanol to jet fuel technology combining Johnson Matthey and Honeywell UOP technologies for sustainable aviation fuel production.
  • ValmetstrategicTechnology or IntegrationJoint development of catalytic pyrolysis technology for production of advanced biofuels. Partnership focused on renewable fuel production processes.
  • VirentstrategicStrategic or Co-development PartnerBioForming technology partnership that enabled the world's first transatlantic commercial flight using 100% sustainable aviation fuel, demonstrating the viability of drop-in SAF.
  • KBRcoreStrategic or Co-development PartnerCombined methanol/ammonia co-production technology partnership using Johnson Matthey and KBR's market-leading technologies for maximized efficiency and operational flexibility.

Scale indicators16 records

Recent moves6 records

Expansion highlights5 records

Johnson Matthey - Medical Device Components Business competitors and assessment

Company assessment

Direct peers

  • Cirtec Medical: Contract manufacturer of active implantables and precision components for cardiac rhythm management, neuromodulation, and other implantable applications — comparable customer base and micromachining/assembly capabilities.
  • Integer Holdings (formerly Greatbatch): Large medical device contract manufacturer specializing in precision components and finished devices for cardiac, neuromodulation, and vascular markets — directly comparable in product category and customer base.
  • Tegra Medical: Contract manufacturer of precision medical devices and components including machining, assembly, and finished devices for surgical and interventional OEMs — comparable in precision-machined medical components.
  • Norman Noble: Specialist in precision micromachining of medical devices and implants, including complex components for cardiovascular, neurovascular, and orthopedic applications — directly comparable on micromachining capability and customer overlap.
  • Helix Medical (Freudenberg Medical): Medical device contract manufacturer of precision silicone and plastic components and finished devices for minimally invasive and surgical applications — overlaps in implantable and interventional device components.
  • Minnetronix: Contract designer/manufacturer of complex medical devices and components, with strength in optical, electronic, and fluid-based systems for neuro and surgical OEMs — comparable as a specialist medtech CDMO.
  • Heraeus Medical Components: Direct competitor in precious-metal components and micromachined parts for implantable medical devices (cardiac, neurovascular, hearing). Closest analog to JM's medical device components offering due to overlap in materials (Pt/Ir, Au, Ta) and implantable device applications.

Broad incumbents

  • Phillips-Medisize (Molex): Large-scale medical device contract manufacturer offering design, molding, and assembly for diagnostics and drug delivery — adjacent rather than direct, but competes for the same OEM program opportunities.
  • West Pharmaceutical Services: Broader medical device components manufacturer focused on elastomeric and specialty containment/delivery components; overlaps with JM medical components in supplying primary packaging and functional components to injectable and device OEMs.
  • Teleflex Medical OEM: Medical device components and specialty extrusion business serving interventional, surgical, and OEM customers — broader incumbent with overlap in precision components for vascular and interventional devices.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights4 records

Customer concentration

Johnson Matthey - Medical Device Components Business social profiles

Digital presence

Johnson Matthey - Medical Device Components Business financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Johnson Matthey - Medical Device Components Business leadership team

Management profile

Number of profiles

Johnson Matthey - Medical Device Components Business subsidiaries and ownership

Company hierarchy

Subsidiaries9 records

Johnson Matthey - Medical Device Components Business funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Johnson Matthey - Medical Device Components Business M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Johnson Matthey - Medical Device Components Business

What does Johnson Matthey - Medical Device Components Business do?

Johnson Matthey's Medical Device Components Business manufactures precious metal and precision micromachined components for medical device manufacturers. The components are designed for use in cardiac rhythm management, neurovascular, cochlear, and vascular intervention applications. As a segment of Johnson Matthey, it leverages the parent company's 200+ years of platinum group metal chemistry expertise to deliver high-precision medical components.

Is Johnson Matthey - Medical Device Components Business a public or private company?

Johnson Matthey - Medical Device Components Business is a public company. It is classified as public and is currently operating.

When was Johnson Matthey - Medical Device Components Business founded?

Johnson Matthey - Medical Device Components Business was founded in 1817. It employs 5,001 to 10,000 people.

Where is Johnson Matthey - Medical Device Components Business based?

Johnson Matthey - Medical Device Components Business is headquartered in London, United Kingdom, in the Europe region.

How does Johnson Matthey - Medical Device Components Business make money?

Five revenue lines are on record. Catalysts and Chemical Products are the primary driver. The others are process Technology Licensing, fuel Cell Components, PGM Refining and Recycling and technical Services and Support.

Who are Johnson Matthey - Medical Device Components Business's main competitors?

Direct peers on record are Cirtec Medical, Integer Holdings (formerly Greatbatch), Tegra Medical, Norman Noble, Helix Medical (Freudenberg Medical), Minnetronix and Heraeus Medical Components. Broad incumbents are Phillips-Medisize (Molex), West Pharmaceutical Services and Teleflex Medical OEM.

Does Johnson Matthey - Medical Device Components Business have an API?

No public API is recorded for Johnson Matthey - Medical Device Components Business.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals